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Equine epizootics of Venezuelan equine encephalitis
(VEE) occurred in the southern Mexican states of Chiapas
in 1993 and Oaxaca in 1996. To assess the impact of con-
tinuing circulation of VEE virus (VEEV) on human and ani-
mal populations, serologic and viral isolation studies were
conducted in 2000 to 2001 in Chiapas State. Human
serosurveys and risk analyses indicated that long-term
endemic transmission of VEEV occurred among villages
with seroprevalence levels of 18% to 75% and that medical
personnel had a high risk for VEEV exposure. Sero-
prevalence in wild animals suggested cotton rats as possi-
ble reservoir hosts in the region. Virus isolations from sen-
tinel animals and genetic characterizations of these strains
indicated continuing circulation of a subtype IE genotype,
which was isolated from equines during the recent VEE
outbreaks. These data indicate long-term enzootic and
endemic VEEV circulation in the region and continued risk
for disease in equines and humans.
V
enezuelan equine encephalitis (VEE) epidemics or
epizootics involving hundreds of thousands of equine
and human cases have occurred in the Americas since the
1930s (1,2). In Mexico, human VEE was first recognized
during the 1960s along the Atlantic coast (3–5). In 1962, a
total of 13 human cases were detected by serologic testing
in Campeche and Champoton, state of Campeche (3,6); 5
deaths occurred (38% case-fatality rate), and 3 patients
exhibited neurologic disease (3). A more extensive sero-
survey in 1962–1964 in four southeastern states found 23
of 770 serum specimens had antibodies against VEEvirus
(VEEV;  Togaviridae:  Alphavirus) (4). Although clinical
cases were not detected during that study, the findings
implied extensive VEEV circulation. During 1963, VEEV
subtype IE was recovered from a sentinel hamster and
mosquitoes collected in southeastern Veracruz State (7). In
1965, a fatal human case occurred in the village of
Jaltipan, Veracruz State (5). Almost simultaneously, equine
epizootics were reported in 1966 in Tamaulipas State and
in northern Veracruz State (8). Although no virus isolations
were made, a VEEV etiology was suggested by serosur-
veys. 
In 1969–1972, a major VEE outbreak began on the
Guatemala-El Salvador border soon after an epizootic
occurred in Ecuador and Peru. The Central American out-
break affected tens of thousands of equines and humans as
it spread northward into Mexico. The first equine deaths
were reported in 1969 in mountainous areas in La
Trinitaria and La Concordia, Chiapas State, close to the
Guatemalan border (8). By 1970, the epidemic and epi-
zootic had caused 10,000 equine deaths and many uncon-
firmed human cases in the states of Chiapas and Oaxaca.
By the end of 1972, nearly 50,000 equine deaths and 93
confirmed human deaths, as well as several hundred non-
fatal human cases, had occurred in Mexico (9,10). The epi-
demic and epizootic eventually reached southern Texas,
where  ≈1,500 horses died and several hundred human
cases occurred (11). This epizoodemic was caused by a
subtype IAB strain and may have been halted in Texas by
equine vaccination, insecticide spraying (12), and possibly
by preexisting natural immunity to other alphaviruses in
the equine population (13). Between 1973 and 1992, no
VEE outbreaks were reported anywhere, prompting specu-
lation that epizootic strains of VEEV had become extinct
(12). However, reemerging VEEV activity in the early and
mid-1990s in Venezuela and Colombia (13,14) and on the
Pacific coast of southern Mexico (15) underscores the con-
tinued threat of VEE in the Americas. 
Venezuelan Equine Encephalitis
Virus, Southern Mexico
José G. Estrada-Franco,* Roberto Navarro-Lopez,† Jerome E. Freier,‡ Dionicio Cordova,§ 
Tamara Clements,¶ Abelardo Moncayo,* Wenli Kang,* Carlos Gomez-Hernandez,# 
Gabriela Rodriguez-Dominguez,# George V. Ludwig,¶ and Scott C. Weaver* 
Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 10, No. 12, December 2004 2113
*University of Texas Medical Branch, Galveston, Texas, USA;
†Comision Mexico-Estados Unidos para la Prevencion de la
Fiebre Aftosa y Otras Enfermedades Exoticas de los Animales,
Mexico, Mexico City, Mexico; ‡U.S. Department of Agriculture,
Fort Collins, Colorado, USA; §Instituto Nacional de
Investigaciones Forestales Agricolas y Pecuarias (INIFAP) Mexico
City, Mexico; ¶U.S. Army Medical Research Institute of Infectious
Diseases, Ft. Detrick, Maryland, USA; and #Instituto de Salud de
la Secretaria de Salud de Chiapas, Tuxtla Gutierrez, Chiapas,
Mexico Two equine epizootics occurred on the Pacific coast of
Mexico in 1993 and 1996. In the summer of 1993 in
coastal areas of Chiapas State, an outbreak affecting125
horses, with 63 deaths, was documented. Three years later,
during the summer of 1996 in the adjacent State of Oaxaca,
another equine epizootic involved 32 horses with 12 deaths
(15). Both outbreaks were caused by a subtype IE VEEV
strain. However, no human cases were documented during
either outbreak. VEEV strains isolated from encephalitic
horses during 1993 and 1996 produced little evidence of
viremia in experimentally infected horses, although the
strains had caused encephalitis (16). Viremia titers were
similar to those generated by enzootic VEEV strains,
which indicates that equines were probably not important
amplifying hosts during either Mexican epizootic.
Two hypotheses could explain the sudden appearance
of equine encephalitis on the Pacific coast of Mexico in
1993: 1) an equine-virulent VEEV variant was introduced
into the region or 2) an enzootic variant circulating previ-
ously in the region became more virulent or began circu-
lating at a higher level in 1993. To test these hypotheses, to
determine whether VEEV has persisted since 1996, and to
determine whether humans are affected by these viruses,
we conducted surveillance during 2000–2001 in various
coastal villages involved in the 1993 epizootic. Our results
indicate that enzootic and endemic VEEV have been cir-
culating in the region and that persons and horses face a
continuing risk for disease. 
Methods
Selection and Description of the Study Area
During the summer of 1999, the Mexican Agricultural
Ministry was notified of a suspected VEE equine outbreak
in coastal areas of Mapastepec and Pijijiapan
Municipalities in the state of Chiapas. A total of 26 equine
cases showing syndromes compatible with equine VEE
were reported, with 23 deaths. All of the affected horses
were 8–14 months of age with no VEEV vaccination his-
tory. Although necropsies were carried out on some
equines, no viruses were isolated. However, three of the
dead horses showed histopathologic changes suggestive of
a nonrabies viral etiology, with VEEV hemagglutination
inhibition (HI) antibody titers from 20 to 5,120 (R.
Navarro-Lopez, unpub. data). Bovine serosurveys also
indicated recent VEEV circulation in the area. 
On the basis of these preliminary data, we selected sev-
eral locations for further study within the La Encrucijada
preserve, a coastal ecosystem of mangrove estuaries and
mangrove forest located along the Pacific coastal plain in
the southwestern portion of the State of Chiapas. The pre-
serve is about 357,824 acres (1,440 km2) and is located
from 14°43′ to 15°40′N and from 92°26′ to 93°20′W. The
area is composed of coastal lagoons, swamps, and marsh-
es forming the largest mangrove forest on the North
American Pacific coast and is important for its biodiversi-
ty and flora, including the only zapotonal woodland
(Pachira acuatica) of Mesoamerica. The flora include
mangrove, zapote forest, marshes, evergreen seasonal for-
est, deciduous seasonal forest, coastal dune vegetation, and
palm forest. The area supports a large variety of threatened
wildlife, including 11 species of amphibians, 34 of reptiles,
294 of birds (94 migratory), and 73 of mammals
(www.ramsar.org/profiles_mexico.htm).
About 30,000 persons live within 64 settlements in the
preserve, and the main activities are commercial fishing,
slash and burn agriculture, and extensive cattle ranching.
We selected seven villages serologically implicated in
VEEV circulation, all located between N
15°46′07′′–15°02′00′′ and W 93° 4′92′′–92°43′00′′ and
within the municipalities of Pijijiapan, Mapastepec, and
Acapetahua (Figure 1). The villages included Las Coaches,
Isla Morelos, Buenavista, 10 de Abril, Francisco Sarabia,
Roberto Barrios, and Las Palmas (Table 1). Two other vil-
lages, Cintalapa and Jamaica, were selected as negative
controls because they are well outside the area affected by
the recent VEE epizootics in the foothills of the Sierra del
Soconusco Mountains, 30–50 km from La Encrucijada. As
part of ongoing dengue surveillance, serum samples from
434 persons from these different locales were tested for
VEEV antibodies.
Animal Trapping and Collection of Serum Specimens
Recommended biosafety methods were used in the
field to minimize the risk for infection of workers by
rodentborne zoonoses (17). Marsupials and rodents were
collected in Tomahawk and Sherman traps. Based on data
provided by the animal exotic disease division of the
Mexican Agricultural Ministry (CPA), the traps were
placed in the periphery (usually next to fences) or inside
farms that recently reported equine encephalitis. Trapped
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Figure 1. Satellite image of the Pacific coastal areas studied for
Venezuelan equine encephalitis virus activity (Landsat thematic
mapper). Bands 4, 5, and 1 are displayed as a red-green-blue
false-color composite. The villages sampled are indicated in yellow.mammals were collected each morning and transferred to
the Agricultural Animal Health Laboratory in Mapastepec,
Chiapas, for processing. After being anesthetized with
halothane, trapped rodents and marsupials were bled by
cardiac puncture, and ≈1 mL of blood was transferred to
vacutainers (Becton Dickinson, Franklin Lake, NJ) for
serum separation. Some rodents were also bled from the
retroorbital sinus with heparinized capillary tubes. Serum
specimens were stored in liquid nitrogen for the subse-
quent analysis at the biosafety level 3 facilities of CPA in
Mexico City or at the University of Texas Medical Branch
in Galveston, Texas. Dog blood samples were obtained by
venipuncture and processed as above. Domestic bird blood
samples were collected from the brachial vein. Cattle
blood samples were collected from the jugular veins. 
Sentinel Animals
Based on human serosurvey data and to maximize
chances for viral isolations, we selected two locations for
exposure of sentinel animals: Las Coaches (75% sero-
prevalence) and Roberto Barrios (54% seroprevalence)
(Figure 1). In Las Coaches we placed ten, 6- to 8-week-old
Syrian hamsters, 1–2 per cage in hamster-baited mosquito
traps as described previously (18). The traps were located
adjacent to marshes at the eastern part of the village, ≈75
m from human dwellings and close to cattle pastures,
swamps, and mangrove forest. In Roberto Barrios, we
exposed four sentinel hamsters in open cages, one hamster
per cage, at four locations at the western tip of the village,
adjacent to marshes and mangrove forest. Hamsters were
monitored daily for 7 consecutive days, and brain, spleen,
heart, and lung were dissected from moribund (euthanized
by halothane overdose) or dead animals and stored in liq-
uid nitrogen. 
Serologic Tests
Initial screening of human serum specimens for VEEV-
reactive antibodies was conducted by using 80% plaque
reduction neutralization tests (PRNT) with subtype IE
strain 68U201, shown previously to be very closely relat-
ed to VEEV strains circulating on the Pacific coast of
Mexico (19). Positive samples (>1:20 titer) were further
analyzed for immunoglobulin (Ig) M by using an antibody
capture enzyme-linked immunoassay (MAC-ELISA)
(20–22). The University of Texas Medical Branch
Institutional Review Board approved screening of all
human sera.
Virus Isolation
Heart and brain tissues from sentinel hamsters were trit-
urated in Eagle’s minimal essential medium (MEM) con-
taining gentamicin and 20% fetal bovine serum to generate
10% suspensions. After centrifugation at 10,000 x g for 5
min, the supernatant was added to Vero cell monolayers
and incubated for 4 days or until cytopathic effects were
evident. VEEV antigen was identified in the Vero cells by
using monoclonal antibodies (23), and VEEV RNA was
detected in the supernatant by using reverse transcrip-
tion–polymerase chain reactions (RT-PCR) as described
previously (19).
Viral Sequencing and Phylogenetic Analyses
Partial or complete VEEV genomic sequences were
determined (19,24). Viral RNAwas extracted from the first
BHK cell passage by using Trizol (Gibco BRL, Bethesda,
MD), according to the manufacturer’s protocol, and sub-
jected to reverse transcription with a primer of sequence
T25V designed to anneal to the poly (25) tract of the
genomic and subgenomic RNA. Complementary DNA
was subjected to PCR by using primers to amplify either
the complete PE2 envelope glycoprotein precursor gene or
the entire viral genome (24). PCR amplicons were purified
with the Qiagen (Valencia, CA) kit according to the manu-
facturer’s protocol and sequenced directly by using the
ABI BigDye kit (Applied Biosystems, Foster City, CA)
and an ABI377 automated sequencer. The sequence of the
5′ terminal 20 nucleotides of the genome was not deter-
mined because the PCR amplicons incorporated primers
corresponding to this region. Sequences were aligned to
homologous GenBank sequences for subtype IE VEEV
strains subtypes, and other VEE complex sequences were
used as outgroups for phylogenetic analyses. Aligned
nucleotide and deduced amino acid sequences were
analyzed by using the maximum parsimony, neighbor-
Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 10, No. 12, December 2004 2115
Venezuelan Equine Encephalitis Virus, Southern Mexicojoining, and maximum likelihood programs in the PAUP 4
package (26). Bootstrap values were determined to assess
the robustness of topologies with 1,000 replicates (27). A
relative rates test was used to estimate the rate of evolution
for VEEV in Mexico and elsewhere.
Statistical Methods
Statistical analyses were performed with Stata (Stata
corp2001. STATA Statistical software release 7.0. College
Station, TX) and EpiInfo 86 (Centers for Disease Control
[CDC]-World Health Organization version 6.04 July 1996,
CDC, Atlanta, GA). We estimated 95% confidence inter-
vals (CI) and tested risk factors by age, sex, location, and
occupation. Where appropriate, chi-square tests and other
statistical approaches were used to test differences in risk
among populations. 
Results
Seroprevalence in Wild Animals and Bovines 
Animals captured with Tomahawk and Sherman traps
were tested for VEEV antibodies by using hemagglutina-
tion inhibition (HI), PRNT, or both, depending on the
capabilities of the laboratory testing the samples. The
results are shown in Table 2. Most notable were opossums,
with an overall seropositivity of 25%, cotton rats
(Sigmodon hispidus) with 67%, and rice rats (Oryzomys
alfaroi) with 17% seropositivity. Cotton rats were suspect-
ed to be the most important reservoir hosts in enzootic
VEEV foci studied in other parts of Mexico and Central
America (28). 
Simultaneously, we conducted a bovine sentinel sero-
survey by testing serum specimens from 20 calves (6–18
months old) from several different farms in and around La
Encrucijada. Of these samples, 14 were VEEV-positive by
PRNT (titers 20–640); 8 of the calves lived within La
Encrucijada Preserve. Subsequently, we bled an additional
110 calves from the same region, and 50 had HI titers from
20–320. Thirty of these also came from La Encrucijada
within a radius of ≈15 km of the mouth of the river
Novillero. The overall 49% seroprevalence in cattle <18
months of age (lifelong residents of the same ranches, as
reported by owners) indicated that bovines are exposed to
VEEV in southern Mexico and are excellent sentinels
because they are fed on by large numbers of mosquitoes,
are susceptible to benign VEEV infection, seroconvert
(29), and are never vaccinated against VEEV.
Human Seroprevalence 
Serum samples from 434 persons who resided in La
Encrucijada were tested for VEEV antibodies. The PRNT
results are summarized by age cohort in Figure 2. The
overall PRNT seropositivity in the region was 37.6%;
38.5% of women and 36.4% of men. Among the different
communities sampled, seropositivity ranged from 4%
(Jamaica) to 75% (Las Coaches; see Table 3). Most notable
was the distribution of seropositivity by age, with rising
rates in the older age groups (Figure 2). The only excep-
tions to this trend were in age groups with small sample
sizes (e.g., 0–5 years of age, 4/10 positive). Assuming that
infection leads to PRNT antibodies lasting >25 years (e.g.,
human antibody responses to the TC-83 live-attenuated
VEEV vaccine can last >30 years (R.E. Shope, pers.
comm.), these data are consistent with a steady rate of
endemic exposure to VEEV during the past 70 years; there
is no suggestion of a disproportionately higher rate in per-
sons  >30 years of age, which would be expected from
exposure during the 1969–1971 Mexican VEE epizootic.
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VEEV in the La Encrucijada region.
Of the PRNT positive human serum specimens, 8 (2%)
were positive by IgM capture ELISA, which indicates
VEEVinfection during the past several months. As was the
case for overall seropositivity, the IgM-positive samples
were relatively evenly distributed among age groups and
sexes (Table 4), which suggests that infections were recent.
The low PRNT titers of some of the IgM-positive samples
could have reflected differences between antigens on the
circulating VEEV strains and those used in the neutraliza-
tion test, or the titers could have decreased between the
time of acute infection.
Risk Analysis for Human Infection 
The risk factor analysis conducted on the inhabitants of
the nine sampled villages showed varying results, accord-
ing to different characteristics of the inhabitants and the
geographic location of their households. Statistically sig-
nificant associations for past VEEV exposure (seropositiv-
ity) were linked to occupation, age, and geographic
location of the village. Analysis of occupations showed
that medical personal had the highest risk (odds ratio [OR]
95.75, 95% CI 10.23–106.93), followed by fisherman
(OR 14.39, 95% CI 4.20–52.22), housewives (OR 5.79,
95% CI 2.20–16.10), and farmers (OR 5.10, 95% CI
1.78–15.32). Results for these categories were compared
to the results for the high school student population.
Additional occupations not statistically associated with
VEEV exposure included junior high school and primary
students and preschool children. With regard to age, the
groups at higher risk of past VEEV exposure were persons
71–90 years of age (OR 8.44, 95% CI 2.18–34.19), fol-
lowed by persons 51–70 years (OR 4.69, 95% CI
2.13–10.41), 41–50 years (OR 7.37, 95% CI 3.2–17.18),
31–40 years (OR 3,41, 95% CI 1.59–7.36), and 21–30
years (OR 4,54, 95 % CI 2.06–10.11). We compared all
the above categories to the age group of children 11–15
years of age. The youngest persons (<10 years of age) had
the lowest risk for past exposure, which is consistent with
endemic VEEV circulation.
The geographic location or address of people also had a
significant association with past VEEV infection, includ-
ing the physical location of the village with respect to the
mangrove forests and marshes. The closer the household
was to these habitats, the higher the risk for their inhabi-
tants being seropositive (OR 11.8, 95 % CI 4.03–38.85).
Isolation of VEEV Strains 
Of a total of 14 hamsters exposed in La Encrucijada
during July, 2001 (98 hamster-days), 10 became ill or died.
Deaths began on the third day after hamster exposure, and
VEEV was isolated from the hearts of five animals
(Table 5). These viruses were confirmed antigenically as
VEEV subtype ID/E by using enzootic subtype-specific
monoclonal antibodies and immunofluorescence (23).
Additionally, several isolates of Group C arboviruses
(Bunyaviridae: Orthobunyavirus) were made. 
Two of the VEEV strains (MX01-22, MX01-32) from
two locations in Las Coaches were selected to assess mark-
ers of the epizootic phenotype and genetic relationships to
Mexican VEEV isolates from the 1993 and 1996 outbreaks.
The partial (856 nucleotides) PE2 envelope glycoprotein
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Figure 2. Rates of Venezuelan equine encephalitis virus (VEEV)
seropositivity by age group for persons living in the La Encrucijada
region. Positive samples had 80% plaque reduction neutralization
test (PRNT) titers of >1:20. Numbers on bars indicate the total
number of serum specimens tested for each age group.precursor gene was sequenced from both isolates
(GenBank accession numbers AY823298 and AY823299)
and both sequences were identical and most closely related
to subtype IE VEEV isolated from the 1996 Oaxaca out-
break. As in previous analyses (19), the Mexican and
Pacific Coastal Guatemalan subtype IE isolates grouped
independently of the Atlantic/Caribbean Central American
and Mexican isolates, as well as the Panama genotype
(Figure 3). However, relationships among the Mexican
strains from the Pacific coast were not well resolved.
Therefore, the complete genome of one strain, MX01-22,
was sequenced. The MX01-22 sequence had only 29
(0.26%) different nucleotides and three different deduced
amino acids when compared to its closest relative, the 1996
equine strain OAX142; phylogenetic reconstruction
showed that the MX01-22 strain is closely related to all of
the 1996 equine isolates (Figure 4). Relative rate analyses
indicated sequence divergence of 2–2.9 x 10–4 subst/nt/year
for this Mexican lineage, similar to estimates of other
enzootic VEEV lineages in South America (30). These data
are consistent with the continuous circulation of a single
major lineage of subtype IE VEEV in coastal Chiapas and
Oaxaca states since 1993. The Guatemalan enzootic lineage
represented by the 1968 and 1980 isolates from La Avellana
on the Pacific coast had a slightly lower estimated sequence
divergence rate of 6.8 x 10–5 subst/nt/year.
Discussion
Endemic and Enzootic VEE in Coastal Chiapas State
Using a combination of human serosurveys, wild and
domestic animal serosurveys, and detection of virus circu-
lation with sentinel hamsters, we obtained evidence that
VEEV circulated in the La Encrucijada area of coastal
Chiapas State for at least several decades before the 1993
epizootic and continues to circulate in an undescribed
transmission cycle. Satellite imagery (Figure 1) and visual
inspections indicate that lowland tropical forest habitats
characteristic of VEEV enzootic foci, including of subtype
IE viruses in other areas of Mexico and the nearby Pacific
coast of Guatemala (31,32), have been almost completely
destroyed for the purposes of cattle ranching and other
agricultural activities. Mosquito collections in La
Encrucijada have indicated an extremely low abundance of
Culex (Melanoconion) taeniopus, the proven enzootic vec-
tor in a coastal Guatemalan subtype IE VEEV focus (33).
This indicates that VEEV is likely using a different mos-
quito species as its enzootic vector in coastal Chiapas
State. Experimental studies indicate that adaptation of the
Mexican VEEV strains for efficient infection of
Ochlerotatus taeniorhynchus mosquitoes, through a muta-
tion in the E2 envelope glycoprotein, may have con-
tributed to epizootic transmission (34).
Seroprevalence in wild animals suggests a possible role
for cotton rats (S. hispidus), implicated previously as a
VEEV reservoir host in other parts of Mexico (28) and in
Panama (35,36). Although the number of animals tested
was small, our data also suggest a possible role for rice rats
(Oryzomys alfaroi) and opossums (Didelphis marsupialis
and  Philander opposum) as vertebrate reservoir hosts
required to maintain horizontal transmission or amplifica-
tion hosts involved in increased circulation, resulting in
equine cases. Other domestic animals, including dogs, cat-
tle, and birds, are also exposed to VEEV in Chiapas State.
Previous experimental studies of dogs (37) and cattle (38)
indicate that low levels of viremia or none develops in
those animals after VEEV infection and, therefore, they
are probably not important as enzootic hosts. Larger sam-
ple sizes and experimental infections to assess viremia lev-
els are needed before conclusions can be drawn regarding
the relative importance of different animals as reservoir or
amplification hosts of VEEV in Mexico.
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increased circulation of VEEV and its transmission to
equines during 1993 and 1996 remain unidentified, since
equines inefficiently amplify the etiologic VEEV strains of
the subtype isolated during the outbreaks (16). One possi-
bility for an alternative amplification host is humans, in
whom high levels of viremia develop after infection by
subtypes IAB and IC VEEV (14,39). Our results indicate
that persons are regularly exposed in coastal Chiapas, and
their migratory work habits could enhance spread during
outbreaks. Estimation of viremia titers from infected per-
sons in southern Mexico is needed to test this hypothesis.
Another possibility is that increased populations of wild
vertebrate hosts such as S. hispidus resulted in increased
amplification of the virus and its transmission to equines
during the summer of 1993.
Human Risk and Disease
Although our data indicate that persons are regularly
infected with VEEV in coastal Chiapas State, the effect of
endemic transmission on human health is unknown. Most
undifferentiated febrile illness in the region is clinically
diagnosed as dengue or flulike febrile illness, and current-
ly no diagnostic tools are in place to test for human VEEV
infections. We identified the occupations of La
Encrucijada inhabitants and the ecologic habitats where
they live and work as risk factors for VEEV infection. We
detected no risk differences between the sexes. A possible
explanation is that, in this region, female homemakers
often accompany male farm laborers to sites where VEEV
may circulate. 
The spatial risks for VEEV infection apparently do not
include proximity to human habitations. Thus, VEEV is
distinct from dengue viruses, which circulate peridomesti-
cally (40). The higher risk for medical personnel for VEEV
infection suggests the possibility of aerosol exposure in
clinical settings. Epidemiologic data on the seasonality of
flulike febrile illness in coastal Chiapas State (Instituto
Mexicano del Seguro Social, unpub. data) indicate peak
incidence from June to November, coincident with the
rainy season and peak mosquito populations. These data
suggest that many flulike illnesses may be caused by
VEEV and possibly other arboviruses such as group C
orthobunyaviruses.
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Figure 3. Maximum parsimony phylogenetic tree derived from par-
tial PE2 envelope glycoprotein precursor gene sequences show-
ing relationships of the newly isolated Venezuelan equine
encephalitis virus (VEEV) strains from sentinel hamsters (Mex01-
22 and Mex01-32) to other subtype IE strains sequenced previ-
ously (19). Strains are designated by country abbreviation followed
by year of isolation and strain designation. Numbers indicate
nucleotide substitutions assigned to each branch. 
Figure 4. Maximum parsimony phylogenetic tree derived from
complete genomic sequences showing relationships of the newly
isolated Venezuelan equine encephalitis virus (VEEV) strain
(MX01-22) to other strains from Mexico and Guatemala. Numbers
indicate nucleotide substitutions assigned to each branch. All
nodes had bootstrap values of 100%, except the OAX131-37820
(62%) and GU68-GU80 (<50%) groupings. Relative rates tests
applied to the branches indicated a rate of nucleotide substitution
in Mexico of 2.0–2.9 x 10-4 subst/nt/y since 1993, and 6.8 x 10-5 for
the Guatemalan lineage from 1968–1980. These data suggest
continuous circulation of VEEV in Mexico since 1993.ecology and epidemiology of vectorborne diseases, their human
impact, vector genetics, and vector-host-pathogen interactions of
arboviruses and parasitic diseases.
References
1.  Beck CE, Wyckoff RWG. Venezuelan equine encephalomyelitis.
Science. 1938;88:530.
2. Albornoz JE. La peste loca de las bestias (Enfermedad de Borna).
Colombia. Min Agr Com, Bogota. Bol de Agr (Suppl). 1935;26:1–8.
3. de Mucha-Macias J. Infecciones por virus arbor. Gaceta Medica de
México. 1963;93:415–20.
4.  de Mucha-Macias J, Sanchez-Spindola I, Campillo-Sainz C.
Venezuelan equine encephalomyelitis antibodies in human beings of
southeastern Mexico. Am J Trop Med Hyg. 1966;15:364–8.
5. Zarate ML, Scherer WF, Dickerman RW. El virus de la encephalitis
equina de Venezuela como determinante de infecciones en humanos,
descripción de un caso fatal ocurrido en Jaltipán Veracruz en 1965.
Rev Invest Salud Publica. 1965;30:296–302.
6. de Mucha-Macias J. Encefalitis equina de Venezuela en Tamaulipas,
Mexico. Rev Invest Salud Publica (Mexico). 1966;26:277–9.
7. Scherer WF, Dickerman RW, Chia CW, Ventura A, Moorhouse A,
Geiger R, et al. Venezuelan equine encephalitis virus in Veracruz,
Mexico, and the use of hamsters as sentinels. Science.
1963;145:274–5.
8. Morilla-Gonzales A, de Mucha-Macias J. Estudio de una epizootia de
encefalitis equina de Venezuela ocurrida en Tamaulipas, Mexico. Rev
Invest Salud Publica (Mexico). 1969;29:3–20.
9. Sudia WD, Newhouse VF, Beadle ID, Miller DL, Johnston JG Jr,
Young R, et al. Epidemic Venezuelan equine encephalitis in North
America in 1971: vector studies. Am J Epidemiol. 1975;101:17–35.
10. Batalla-Campero D. Adaptación , modificaciones y pruebas de campo
para el desarrollo de una vacuna contra la Encefalitis Equina
Venezolana (EEV). In: Trabajos deingreso de Académicos
Numerarios y Correspondientes. Mexico City: Academia Veterinaria
Mexicana AC; 1995. p. 16–24.
11. Calisher CH. Medically important arboviruses of the United States
and Canada. Clin Microbiol Rev. 1994;7:89–116.
12. Walton TE, Grayson MA. Venezuelan equine encephalomyelitis. In:
Monath TP. The arboviruses: epidemiology and ecology, vol. IV.
Boca Raton (FL): CRC Press; 1988. p. 203–31.
13.  Rico-Hesse R, Weaver SC, de Siger J, Medina G, Salas RA.
Emergence of a new epidemic/epizootic Venezuelan equine
encephalitis virus in South America. Proc Natl Acad Sci U S A.
1995;92:5278–81.
14. Weaver SC, Salas R, Rico-Hesse R, Ludwig GV, Oberste MS, Boshell
J, et al. Re-emergence of epidemic Venezuelan equine encephalo-
myelitis in South America. VEE Study Group. Lancet.
1996;348:436–40.
15. Oberste MS, Fraire M, Navarro R, Zepeda C, Zarate ML, Ludwig GV,
et al. Association of Venezuelan equine encephalitis virus subtype IE
with two equine epizootics in Mexico. Am J Trop Med Hyg.
1998;59:100–7.
16. Gonzalez-Salazar D, Estrada-Franco JG, Carrara AS, Aronson JF,
Weaver SC. Equine Amplification and virulence of subtype IE
Venezuelan equine encephalitis viruses isolated during the 1993 and
1996 Mexican epizootics. Emerg Infect Dis. 2003;9:161–8.
17. Mills JN, Childs JE, Ksiazek TG, Peters CJ. Methods for trapping and
sampling small mammals for virologic testing. Atlanta: U.S.
Department of Health and Human Services; 1995. p. 61.
18. Ferro C, Boshell J, Moncayo AC, Gonzalez M, Ahumada ML, Kang
W, et al. Natural enzootic vectors of Venezuelan equine encephalitis
virus, Magdalena Valley, Colombia. Emerg Infect Dis. 2003;9:49–54.
19. Oberste MS, Schmura SM, Weaver SC, Smith JF. Geographic distri-
bution of Venezuelan equine encephalitis virus subtype IE genotypes
in Central America and Mexico. Am J Trop Med Hyg.
1999;60:630–4.
20. Chu YK, Rossi C, Leduc JW, Lee HW, Schmaljohn CS, Dalrymple
JM. Serological relationships among viruses in the Hantavirus genus,
family Bunyaviridae. Virology 1994;198:196–204.
21. Schmaljohn C, Vanderzanden L, Bray M, Custer D, Meyer B, Li D,
et al. Naked DNA vaccines expressing the prM and E genes of
Russian spring summer encephalitis virus and Central European
encephalitis virus protect mice from homologous and heterologous
challenge. J Virol. 1997;71:9563–9.
22. Tardei G, Ruta S, Chitu V, Rossi C, Tsai TF, Cernescu C. Evaluation
of immunoglobulin M (IgM) and IgG enzyme immunoassays in sero-
logic diagnosis of West Nile Virus infection. J Clin Microbiol.
2000;38:2232–9.
23. Roehrig JT, Bolin RA. Monoclonal antibodies capable of distinguish-
ing epizootic from enzootic varieties of Subtype I Venezuelan equine
encephalitis viruses in a rapid indirect immunofluorescence assay. J
Clin Microbiol. 1997;35:1887–90.
24.  Brault AC, Powers AM, Holmes EC, Woelk CH, Weaver SC.
Positively charged amino acid substitutions in the E2 envelope gly-
coprotein are associated with the emergence of Venezuelan equine
encephalitis virus. J Virol. 2002;76:1718–30.
25. Encephalitis, Venezuelan equine, 30 years of study in Venezuela,
1963–1993. Invest Clin. 1995;36(Suppl 2):1–565.
26. Swofford DL. PAUP*. Phylogenetic Analysis Using Parsimony (*and
Other Methods). Version 4. Sunderland (MA): Sinauer Associates;
1998. 
27. Felsenstein J. Confidence limits on phylogenies: an approach using
the bootstrap. Evolution. 1985;39:783–91.
28. Scherer WF, Dickerman RW, La Fiandra RP, Wong Chia C, Terrian J.
Ecologic studies of Venezuelan encephalitis virus in southeastern
Mexico. IV. Infections of wild mammals. Am J Trop Med Hyg.
1971;20:980–8.
29. Walton TE, Johnson KM. Experimental Venezuelan equine
encephalomyelitis virus infection of the bovine. Infect Immun.
1972;5:155–9.
30. Brault AC, Powers AM, Medina G, Wang E, Kang W, Salas RA, et al.
Potential sources of the 1995 Venezuelan equine encephalitis subtype
IC epidemic. J Virol. 2001;75:5823–32.
31. Dickerman RW, Scherer WF, Diaz-Najera A. Ecologic studies of
Venezuelan encephalitis virus in southeastern Mexico. I. Introduction
and study sites. Am J Trop Med Hyg. 1971;20:730–9.
32. Scherer WF, Dickerman RW, Ordonez JV, Seymour C 3rd, Kramer
LD, Jahrling PB, et al. Ecologic studies of Venezuelan encephalitis
virus and isolations of Nepuyo and Patois viruses during 1968–1973
at a marsh habitat near the epicenter of the 1969 outbreak in
Guatemala. Am J Trop Med Hyg. 1976;25:151–62.
33. Cupp EW, Scherer WF, Ordonez JV. Transmission of Venezuelan
encephalitis virus by naturally infected Culex (Melanoconion)
opisthopus. Am J Trop Med Hyg. 1979;28:1060–3.
34. Brault AC, Powers AM, Ortiz D, Estrada-Franco JG, Navarro-Lopez
R, Weaver SC. Venezuelan equine encephalitis emergence: enhanced
vector infection from a single amino acid substitution in the envelope
glycoprotein. Proc Natl Acad Sci U S A. 2004;101:11344–9.
35. Grayson MA, Galindo P. Ecology of Venezuelan equine encephalitis
virus in Panama. J Am Vet Med Assoc. 1969;155:2141–5.
36. Young NA, Johnson KM, Gauld LW. Viruses of the Venezuelan
equine encephalomyelitis complex. Experimental infection of
Panamanian rodents. Am J Trop Med Hyg. 1969;18:290–6.
37. Dickerman RW, Scherer WF, Navarro E, Ordonez M, Ordonez JV.
The involvement of dogs in endemic cycles of Venezuelan encephali-
tis virus. Am J Epidemiol. 1973;98:311–4.
2120 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 10, No. 12, December 2004
RESEARCH38. Dickerman RW, Baker GJ, Ordonez JV, Scherer WF. Venezuelan
equine encephalomyelitis viremia and antibody responses of pigs and
cattle. Am J Vet Res. 1973;34:357–61.
39.  Bowen GS, Calisher CH. Virological and serological studies of
Venezuelan equine encephalomyelitis in humans. J Clin Microbiol.
1976;4:22–27.
40. Gubler DJ. Dengue and dengue hemorrhagic fever: its history and
resurgence as a global public health problem. In: Gubler DJ, Kuno G.
Dengue and dengue hemorrhagic fever. New York: CAB
International; 1997. p. 1–22.
Address for correspondence: Scott Weaver, Department of Pathology,
University of Texas Medical Branch, Galveston, TX 77555-0609, USA;
fax 409-747-2415; email: sweaver@utmb.edu
Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 10, No. 12, December 2004 2121
Venezuelan Equine Encephalitis Virus, Southern Mexico
Search   past   issues   of   EID   at   www.cdc.gov/eid
Use of trade names is for identification only and does not imply
endorsement by the Public Health Service or by the U.S.
Department of Health and Human Services.